Business Description
Evogene Ltd
ISIN : IL0011050551
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.87 | |||||
Equity-to-Asset | 0.08 | |||||
Debt-to-Equity | 3.65 | |||||
Debt-to-EBITDA | -0.6 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -9.87 | |||||
Beneish M-Score | -0.32 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 49.5 | |||||
3-Year EBITDA Growth Rate | 14.8 | |||||
3-Year EPS without NRI Growth Rate | 14.1 | |||||
3-Year FCF Growth Rate | 12 | |||||
3-Year Book Growth Rate | -43.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 23.01 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 91.77 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 80.4 | |||||
9-Day RSI | 63.04 | |||||
14-Day RSI | 49.25 | |||||
6-1 Month Momentum % | -58.13 | |||||
12-1 Month Momentum % | -49.01 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.58 | |||||
Quick Ratio | 1.53 | |||||
Cash Ratio | 1.28 | |||||
Days Inventory | 80.97 | |||||
Days Sales Outstanding | 21.6 | |||||
Days Payable | 250.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.4 | |||||
Shareholder Yield % | -46.71 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 81.41 | |||||
Operating Margin % | -232.82 | |||||
Net Margin % | -210.25 | |||||
FCF Margin % | -214.64 | |||||
ROE % | -176.73 | |||||
ROA % | -39.74 | |||||
ROIC % | -107.88 | |||||
3-Year ROIIC % | 23.63 | |||||
ROC (Joel Greenblatt) % | -666.81 | |||||
ROCE % | -51.55 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.62 | |||||
PB Ratio | 5.1 | |||||
EV-to-EBIT | -0.33 | |||||
EV-to-Forward-EBIT | -0.72 | |||||
EV-to-EBITDA | -0.38 | |||||
EV-to-Forward-EBITDA | -1.18 | |||||
EV-to-Revenue | 0.75 | |||||
EV-to-Forward-Revenue | 0.36 | |||||
EV-to-FCF | -0.35 | |||||
Price-to-Median-PS-Value | 0.07 | |||||
Earnings Yield (Greenblatt) % | -303.03 | |||||
FCF Yield % | -120.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Evogene Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 35.168 | ||
EPS (TTM) (₪) | -14.588 | ||
Beta | 0 | ||
Volatility % | 60.04 | ||
14-Day RSI | 49.25 | ||
14-Day ATR (₪) | 0.560795 | ||
20-Day SMA (₪) | 10.7081 | ||
12-1 Month Momentum % | -49.01 | ||
52-Week Range (₪) | 9.35 - 37 | ||
Shares Outstanding (Mil) | 5.37 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Evogene Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Evogene Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Evogene Ltd Frequently Asked Questions
What is Evogene Ltd(XTAE:EVGN)'s stock price today?
When is next earnings date of Evogene Ltd(XTAE:EVGN)?
Does Evogene Ltd(XTAE:EVGN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |